clinical trial · NCT05976230
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
HypertensionEntresto
brief summary
This is a single arm, multicenter, observational study to evaluate the safety and efficacy of Entresto Tablets during the first 52 weeks of treatment in Japanese patients with hypertension.
started
Sep 4, 2023
primary completion
May 29, 2025
completion
May 29, 2025
last updated
Jul 3, 2025
detailed description
This study is a special drug use surveillance to collect information on the safety specifications under the actual clinical practice of Entresto Tablets in patients with hypertension in Japan to confirm the occurrence and timing of onset of events related to the safety specifications and investigate their risk factors.
official title
Special Drug Use Surveillance of Entresto Tablets (Hypertension, CLCZ696A1402): ENLIGHT
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol